Intensity-modulated radiation therapy for breast: Is it for everyone? Journal Article


Authors: McCormick, B.; Hunt, M.
Article Title: Intensity-modulated radiation therapy for breast: Is it for everyone?
Abstract: Intensity-modulated radiation therapy (IMRT) became available to the radiation oncology community in the late 1990s, and its initial applications were to increase conformality of dose to the target, allowing for both dose escalation and decreased radiation to adjacent normal organs. In most disease sites, these continue to be the goals of IMRT. However, for breast cancer, IMRT has emerged with a different endpoint, namely improving dose homogeneity throughout the targeted breast. In 2 recent prospective randomized trials comparing IMRT with "standard" planning, IMRT was associated with a significant decrease in both acute side effects and late fibrosis, which was related directly to dose homogeneity. Better conformality can also be achieved with IMRT; yet because of the unique location of the breast tissue external to the thoracic contents, attempts at "inverse planning" with multiple fields were largely not perceived as "better" plans when treating the breast alone. Research is underway to determine if the use of IMRT for breast or chest wall along with regional lymphatics may improve outcomes over "standard" treatment planning. Additionally, special anatomic situations, such as pectus excavatum, have been shown to benefit from IMRT. © 2011 Elsevier Inc.
Keywords: treatment outcome; clinical trial; intensity modulated radiation therapy; treatment planning; skin manifestation; cancer radiotherapy; radiation dose; pain; breast cancer; radiation injury; lymph vessel; telangiectasia; collimator; computer assisted radiotherapy; breast surgery; breathing mechanics; application site desquamation; breast fibrosis; funnel chest; respiration control; thorax wall cancer
Journal Title: Seminars in Radiation Oncology
Volume: 21
Issue: 1
ISSN: 1053-4296
Publisher: Elsevier Inc.  
Date Published: 2011-01-01
Start Page: 51
End Page: 54
Language: English
DOI: 10.1016/j.semradonc.2010.08.009
PROVIDER: scopus
PUBMED: 21134654
DOI/URL:
Notes: --- - "Export Date: 4 March 2011" - "CODEN: SRONE" - "Source: Scopus"
Altmetric
Citation Impact
MSK Authors
  1. Beryl McCormick
    359 McCormick
  2. Margie A Hunt
    286 Hunt
Related MSK Work